Related Experiment Videos
[General anesthesia in a patient with catecholaminergic polymorph ventricular tachycardia]
1Service d'Anesthésie-Réanimation Chirurgicale, Hôpital de Hautepierre, Strasbourg.
Annales Francaises D'Anesthesie Et De Reanimation
|January 1, 1995
Summary
Nadolol-treated patients with catecholaminergic polymorphic ventricular tachycardia may experience bidirectional ventricular tachycardia during anesthesia induction, potentially triggered by pancuronium. Careful anesthetic management is crucial for these high-risk cardiac patients.
Area of Science:
- Cardiology
- Anesthesiology
- Pharmacology
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare genetic disorder causing life-threatening arrhythmias.
- Nadolol is a beta-blocker commonly used to manage CPVT.
- Dental extractions under general anesthesia pose risks for patients with cardiac conditions.
Observation:
- A CPVT patient on nadolol presented for dental extractions.
- During anesthetic induction, the patient's heart rate dropped to 30-35 bpm.
- An episode of bidirectional ventricular tachycardia occurred.
Findings:
- The bidirectional ventricular tachycardia episode was likely induced by pancuronium administration.
- This suggests pancuronium may trigger arrhythmias in CPVT patients, even with beta-blocker treatment.
Implications:
- Anesthetic protocols for CPVT patients require careful consideration of neuromuscular blocking agents.
- Further research is needed to understand the interaction between pancuronium and CPVT.
- This case highlights the importance of vigilant cardiac monitoring during anesthesia in high-risk patients.